Company:  DEXCOM INC (DXCM)
Form Type:  8-K
Filing Date:  3/28/2013 
CIK:  0001093557 
Address:  6340 SEQUENCE DRIVE 
City, State, Zip:  SAN DIEGO, California 92121 
Telephone:  (858) 200-0200 
Fiscal Year:  12/31 
Last Trade
Last Trade: 
$34.68  
Change: 
-1.33 (-3.69%)  
Trade Time: 
Apr 24  
Market Cap: 
$2.59B
Description of Business
DexCom, Inc. is a medical device company focused on the design, development and commercialization of continuous glucose monitoring systems for ambulatory use by people with diabetes and for use by healthcare providers in the hospital for the treatment of patients with and without diabetes. Unless the context requires otherwise, the terms �we,� �us,� �our,� the �company,� or �DexCom� refer to DexCom, Inc. and its subsidiaries. Ambulatory Product Line: SEVEN� PLUS, DexCom G4� and DexCom G4� PLATINUM We received approval from the Food and Drug Administration (�FDA�) and commercialized our first product in 2006. In 2007, we received approval and began commercializing our second generation system, the DexCom SEVEN. We no longer market or provide support for the DexCom SEVEN system.
Register for EDGAR Pro and access this filing in:     
  FORM 8-K
    SECTION 1 BUSINESS AND OPERATIONS
      Item 1.01. Entry into a Material Definitive Agreement
    SECTION 5 CORPORATE GOVERNANCE
      Item 5.02. Departure of Directors or Certain Officers; ...
    SIGNATURES
BROKERAGE PARTNERS